Live Breaking News & Updates on Advanced Prostate

Stay updated with breaking news from Advanced prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PATIENTS IN SCOTLAND WITH AN ADVANCED FORM OF PROSTATE CANCER CAN NOW ACCESS LYNPARZA (OLAPARIB) WITH ABIRATERONE AND PREDNISONE OR PREDNISOLONE WITHOUT A BIOMARKER TEST

PATIENTS IN SCOTLAND WITH AN ADVANCED FORM OF PROSTATE CANCER CAN NOW ACCESS LYNPARZA (OLAPARIB) WITH ABIRATERONE AND PREDNISONE OR PREDNISOLONE WITHOUT A BIOMARKER TEST ....

City Of , United Kingdom , United States , Robert Jones , David Long , Ptom Keith Roach , University Of Glasgow , Scottish Medicine Consortium , Professor Of Clinical Cancer Research , Urology Care Foundation , Scottish Medicines Consortium , Merck Co Inc , International Journal Of Clinical Practice , Clinical Cancer Research , Astrazeneca United Kingdom , Metastatic Castration Resistant Prostate , International Journal , Eurology Care , Prostate Cancer , Current Treatment Options , Promising New , Real World Clinical Practice Setting , Medicines Compendium , Product Characteristics , Rare Diseases , Olaparib Plus Abiraterone ,

Black Men With Advanced Prostate Cancer Are Less Likely to Get the Most Effective Therapies

Learn about disparities in the use of second-generation androgen receptor inhibitors for prostate cancer and how to improve outcomes. ....

United States , Michael Xiang , David Geffen School Of Medicine , Advanced Prostate , David Geffen School , Systemic Inequalities , Provider Bias ,

FDA Gives Cancer Drug Updates, Prostate Cancer Trial Enrolls Patients

Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more. ....

Drug Administration , Metastatic Cervical , Biologics License Application , Manufacturing Concerns , Missed Gastric Cancer Drug , Study Evaluating , Advanced Prostate , Drug Shows , Disease Control Rate , Cervical Cancer , Prostate Cancer , Gastric Cancer , Waldenstrom X27s Macroglobulinemia ,

NCCN Announces Funding for Advanced Prostate Cancer Research Projects

/PRNewswire/ The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced grants awarded for developing innovative. ....

Kelly Stratton , Sagar Patel , Satish Choudhury , Sean Sachdev , Ou Health Stephenson Cancer Center , University Of Oklahoma Health Sciences , National Comprehensive Cancer Network , Northwestern University , Winship Cancer Institute Of Emory University , Roberth Lurie Comprehensive Cancer Center , Dana Farber Cancer Institute , Scientific Review Committee , Chief Executive Officer , Dana Farber Cancer , Long Course , Hormone Sensitive Prostate Cancer , Winship Cancer Institute , Controlled Trial , Abiraterone Acetate , Advanced Prostate , Comprehensive Cancer Center , Advanced Multi Imaging Response Evaluation , Very High Risk Prostate Cancer , Stephenson Cancer Center , Oklahoma Health , Local Regional Treatment ,